Page 422 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

396 Rami N. Al-Rohil and J. Andew Carlson

[43] Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis, and response to
treatment in polyarteritis. Mayo Clin. Proc. 1980; 55:146-155.

[44] Decleva I, Marzano AV, Barbareschi M, et al. Cutaneous manifestations in systemic
vasculitis. Clin. Rev. Allergy Immunol. 1997; 15:5-20.

[45] Pagnoux C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients
with polyarteritis nodosa: a systematic retrospective study of patients diagnosed
between 1963 and 2005 and entered into the French Vasculitis Study Group Database.
Arthritis Rheum. 2010; 62:616-626.

[46] Carlson JA, Chen KR. Cutaneous vasculitis update: neutrophilic muscular vessel and
eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am. J.
Dermatopathol. 2007; 29:32-43.

[47] Al-Daraji W, Gregory AN, Carlson JA. "Macular arteritis": a latent form of cutaneous
polyarteritis nodosa? Am. J. Dermatopathol. 2008; 30:145-149.

[48] Fein H, Sheth AP, Mutasim DF. Cutaneous arteritis presenting with hyperpigmented
macules: macular arteritis. J. Am. Acad. Dermatol. 2003; 49:519-522.

[49] Sadahira C, Yoshida T, Matsuoka Y,et al. Macular arteritis in Japanese patients. J. Am.
Acad. Dermatol. 2005; 52:364-366.

[50] Saleh Z, Mutasim DF. Macular lymphocytic arteritis: a unique benign cutaneous
arteritis, mediated by lymphocytes and appearing as macules. J. Cutan Pathol. 2009;
36:1269-1274.

[51] Lee JS, Kossard S, McGrath MA. Lymphocytic thrombophilic arteritis: a newly
described medium-sized vessel arteritis of the skin. Arch. Dermatol. 2008; 144:1175-
1182.

[52] Macarenco RS, Galan A, Simoni PM, et al. Cutaneous lymphocytic thrombophilic
(macular) arteritis: a distinct entity or an indolent (reparative) stage of cutaneous
polyarteritis nodosa? Report of 2 cases of cutaneous arteritis and review of the
literature. Am. J. Dermatopathol. 2013; 35:213-219.

[53] Segura S, Pujol RM, Trindade F, et al. Vasculitis in erythema induratum of Bazin: a
histopathologic study of 101 biopsy specimens from 86 patients. J. Am. Acad.
Dermatol. 2008; 59:839-851.

[54] Dalton SR, Fillman EP, Ferringer T, et al. Smooth muscle pattern is more reliable than
the presence or absence of an internal elastic lamina in distinguishing an artery from a
vein. J. Cutan Pathol. 2006; 33:216-219.

[55] Yus ES, Simon P. About the histopathology of erythema induratum-nodular vasculitis.
Am. J. Dermatopathol. 1999; 21:301-306.

[56] Fukuda MV, Lo SC, de Almeida CS, et al. Anti-Ro antibody and cutaneous vasculitis in
systemic lupus erythematosus. Clin. Rheumatol. 2009; 28:301-304.

[57] Shinjo SK, Bonfá E. Cutaneous vasculitis in systemic lupus erythematosus: association
with anti-ribosomal P protein antibody and Raynaud phenomenon. Clin. Rheumatol.
2011; 30:173-177.

[58] Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin
Arthritis Rheum. 2006; 36:88-98.

[59] Puéchal X, Said G, Hilliquin P, et al. Peripheral neuropathy with necrotizing vasculitis
in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients.
Arthritis Rheum. 1995; 38:1618-1629.

Complimentary Contributor Copy